Amazing Single Center study using Methotrexate (~15/wk) prophylaxis in 10 pts starting IV pegloticase for refractory gout - ALL responded; no immunogenicity, no rise in SUA. Another way of preventing interference by anti-PEG Abs. #ACR18, Abstr #1286 https://t.co/D4oWLNYaPE

• https://buff.ly/2OQ5kIK

Remember cutaneous lupus can be caused by medication. This changes our treatment. https://t.co/UQZE65aOFk

• Marco S Massarotti on Twitter: "Worth bearing in mind! #ACR18… "

ACR18 Insights >>> Published by Sjögrens Forum in Twitter: RT @KDAO2011: My top 3 takehomes from #ACR18 are: @rheumnow 1. ACR is thinking about leaving ABIM & join ABAI to form a new board certifyin… https://t.co/92qBxCVC6h #ACR18 #LucidQuest #followthepatient https://t.co/S1YHIXgoAS

• http://dlvr.it/Qpbsf6

#Methotrexate and #leflunomide survival in #patients with #psoriatic #arthritis Know more: https://t.co/kGlBeVFDzb https://t.co/1Nbq18Ai2O

• https://bit.ly/2AqSFDi

Let's dig into today's announcement by @Potus & Dept of Health & Human Services to reduce #drugprices in Medicare Part B, from a rheumatology perspective. Read & retweet! First: what was it? It's an Advance Notice of Proposed Rulemaking (ANPRM). Link: https://t.co/ytxKpbElle 1/N

• https://www.cms.gov/sites/drupal/files/2018-10/10-25-2018%20CMS-5528-ANPRM.PDF

This legitimately takes <1 min to do (see form in pic), and will help us avoid reimbursement cuts that would be disasterous for rheumatologists and our patiehts https://t.co/9FuirqGRod https://t.co/IxKeljB95O

• Angus Worthing MD on Twitter: &quot;Most high yield thing to do to stop E/M cut…

New ACR guidelines for treatment management during pregnancy in patients with rheumatic diseases #ACR18 > AM https://t.co/RKhFHFJMt7

Patient safety is a critical part of Lilly's commitment to improving the rheumatoid arthritis treatment experience https://t.co/h4LD2oOOD3 #ACR18 https://t.co/ctXpr17Iar

• http://elil.ly/a3nm

It’s the psoriatic arthritis equivalent of watching Coltrane, Louis Armstrong and Duke Ellington on the same stage #ACR18 @RheumNow https://t.co/zGiJS6IDcS

Comprehensive list of differential diagnosis of aortitis at vasculitis MOC session today. 1/3 of IgG4RD patients have vascular involvement (vasculitis+perivasc infiltrate) #ACR18 https://t.co/yu5ZO2dzCA

So proud of my dad for his hard work this year and his inspiring speech about the ACR's role in the future of medicine and politics! Also sincerely grateful for the opportunity to join in on so many of his trips and for always being so welcomed by the ACR. #ACR18 #Chicago https://t.co/fMQPLzMCcw

In depth discussion on capillaroscopy by Dr. Cutolo. #ACR18 https://t.co/ni3HT94ue4

Worth bearing in mind! #ACR18 https://t.co/07J8wj0j2C

1.Major political issues currently at stake for rheumatologists (eg CMS cuts for E/M service, step therapy) & need ⬆️ @ACRheum member help cc:@AngusWorthing 2.PEXIVAS: *negative* study on pheresis in severe AAV 3. Aggressive tx in MDA5+DM w/pred+CYC+tacro ⬆️survival #ACR18 https://t.co/TX6muMR3nO

• Arthur Lau on Twitter: &quot;Had a great time at #ACR18. What were your top 3 t…